Zoom On: Professor Rinaldo Bellomo - ICU Management Editorial Board Member
We asked Professor Bellomo our 7 questions:
1. What are your key areas of interest and research?
Sepsis, acute kidney injury, haemodynamics and trials.
2. What are the major challenges in your field?
Obtaining high level evidence.
3. What is your top management tip?
Create a team and select the right people.
4. What would you single out as a career highlight?
Conducting large double-blinded multicentre trials.
5. If you had not chosen this career path you would have become a..?
6. What are your personal interests outside of work?
7. Your favourite quote?
"It always seems impossible until it's done" - Mandela.
Professor Bellomo has received more than 60 national and international awards, co-managed NHMRC grants for a total of more than A$35 million, delivered lectures at over 150 national and international conferences, and authored more than 800 PubMed cited papers. He is editor-in chief-of Critical Care and Resuscitation, the official journal of the College of Intensive Care Medicine of Australia and New Zealand.
Published on : Thu, 1 May 2014
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....
Monitor vital signs of sensitive patients with reliable, smart and intuitive technology Not available in the US Sensitive patients, like neonates, require comfortable care. With transcutaneous monitoring, you can easily keep track of the oxygenation...